Copyright
©The Author(s) 2025.
World J Orthop. Dec 18, 2025; 16(12): 110291
Published online Dec 18, 2025. doi: 10.5312/wjo.v16.i12.110291
Published online Dec 18, 2025. doi: 10.5312/wjo.v16.i12.110291
Table 1 Patient demographic characteristics
| Demographics | Value |
| Gender (male/female) | 45/28 |
| Age (years) | 39.10 ± 11.22 (21-67) |
| BMI (kg/m2) | 23.00 ± 3.48 |
| Follow up time (month) | 53.58 ± 26.80 (18-129) |
| THA (hips) | 7 |
| Hip preservation surgery (hips) | 4 |
| Etiology (hips) | |
| Steroid | 59 |
| Alcohol | 22 |
| Trauma | 13 |
| Idiopathic | 25 |
| ARCO stage (hips) | |
| Stage I | 2 |
| Stage II | 41 |
| Stage IIIa | 59 |
| Stage IIIb | 17 |
| JIC classification (hips) | |
| Type A | 12 |
| Type B | 26 |
| Type C1 | 54 |
| Type C2 | 27 |
| Lesion size (hips) | |
| < 15% | 26 |
| 15%-30% | 37 |
| > 30% | 56 |
| Collapse degree (hips) | |
| ≤ 2 mm | 102 |
| > 2 mm | 17 |
Table 2 Kappa consistency coefficients for radiological data assessment at the initial visit
| Items | Intra-observer kappa | Inter-observer | ||
| Observer 1 | Observer 2 | Kappa | P value | |
| AROC stage | 0.431 | 0.590 | 0.403 | < 0.001 |
| JIC classification | 0.706 | 0.771 | 0.796 | < 0.001 |
| Lesion size | 0.813 | 0.802 | 0.656 | < 0.001 |
| Collapse degree | 0.627 | 0.804 | 0.525 | < 0.001 |
Table 3 Kappa consistency coefficients for radiological data at the final follow-up
| Items | Intra-observer kappa | Inter-observer | ||
| Observer 1 | Observer 2 | Kappa | P value | |
| AROC stage | 0.942 | 0.454 | 0.504 | < 0.001 |
| JIC classification | 0.928 | 0.374 | 0.348 | < 0.001 |
| Lesion size | 0.959 | 0.492 | 0.430 | < 0.001 |
| Collapse degree | 0.895 | 0.638 | 0.666 | < 0.001 |
Table 4 Results of Harris Hip Score, international Hip Outcome Tool 12, visual analogue scale, and Western Ontario and McMaster Universities Arthritis Index before treatment and at the last follow-up
| Items | Pre-treatment | Post-treatment | Z | P value |
| HHS | 61.00 (77.00, 51.00) | 75.00 (93.00, 67.00) | -9.389 | < 0.001 |
| iHOT-12 | 72.00 (80.00, 63.00) | 102.00 (110.00, 94.00) | -9.472 | < 0.001 |
| WOMAC | 90.00 (99.00, 75.00) | 45.00 (63.00, 29.00) | -9.472 | < 0.001 |
| VAS | 7.00 (7.00, 6.00) | 3.00 (4.00, 2.00) | -9.326 | < 0.001 |
Table 5 Overall distribution of clinical scores in patients pre-treatment and at the last follow-up
| Items | Pre-treatment | Post-treatment | χ2 | P value |
| ARCO stage (hips) | ||||
| Stage I | 2 | 2 | 31.966 | < 0.0011 |
| Stage II | 41 | 31 | ||
| Stage IIIa | 59 | 34 | ||
| Stage IIIb | 17 | 39 | ||
| Stage IV | 0 | 13 | ||
| JIC classification (hips) | ||||
| Type A | 12 | 15 | 7.071 | 0.070 |
| Type B | 26 | 21 | ||
| Type C1 | 54 | 51 | ||
| Type C2 | 27 | 32 | ||
| Lesion size (hips) | ||||
| < 15% | 26 | 28 | 5.485 | 0.140 |
| 15%-30% | 37 | 30 | ||
| > 30% | 56 | 61 | ||
| Collapse degree (hips) | ||||
| ≤ 2 mm | 102 | 67 | 25.002 | < 0.001 |
| > 2 mm | 17 | 52 | ||
Table 6 Success rate of hip preservation
| Items | Number of hips | Conversion to THA | Conversion to HPS | Success rate | χ2 | P value |
| ARCO stage (hips) | ||||||
| Stage I, II | 43 | 1 | 0 | 97.67% | 8.736 | 0.011 |
| Stage IIIa | 59 | 2 | 3 | 91.53% | ||
| Stage IIIb | 17 | 4 | 1 | 70.59% | ||
| JIC classification (hips) | ||||||
| Type A, B | 38 | 0 | 1 | 97.37% | 6.521 | 0.031 |
| Type C1 | 54 | 2 | 2 | 92.59% | ||
| Type C2 | 27 | 5 | 1 | 77.78% | ||
| Lesion size (hips) | ||||||
| < 15% | 26 | 2 | 1 | 88.46% | 0.798 | 0.771 |
| 15%-30% | 37 | 2 | 2 | 89.19% | ||
| > 30% | 56 | 3 | 1 | 92.86% | ||
| Collapse degree (hips) | ||||||
| ≤ 2 mm | 102 | 3 | 3 | 94.12% | 9.616 | 0.009 |
| > 2 mm | 17 | 4 | 1 | 70.59% | ||
Table 7 Clinical scores after conservative hip preservation treatment for osteonecrosis of the femoral head based on Association Research Circulation Osseous stages
| Items | ARCO I, II | ARCO IIIa, b | Z | P value |
| Harris | 81.00 (93.00, 67.00) | 75.00 (86.50, 66.25) | -1.133 | 0.257 |
| iHOT-12 | 106.00 (114.00, 96.00) | 101.00 (109.50, 91.00) | -1.877 | 0.060 |
| WOMAC | 43.00 (62.00, 20.00) | 46.00 (63.00, 33.00) | -1.822 | 0.069 |
| VAS | 3.00 (3.00, 0.00) | 3.00 (6.00, 3.00) | -2.286 | 0.007 |
Table 8 Clinical scores after conservative hip preservation treatment for osteonecrosis of the femoral head based on Japanese Investigation Committee classification
| Items | JIC A, B | JIC C1 | JIC C2 | F/H | P value |
| Harris | 75.50 (93.00, 65.00) | 75.00 (93.00, 63.00) | 77.00 (95.00, 67.00) | 0.714 | 0.7001 |
| iHOT-12 | 104.00 (112.00, 96.00) | 101.00 (108.50, 93.75) | 98.00 (110.00, 92.00) | 2.077 | 0.3541 |
| WOMAC | 44.47 ± 24.55 | 49.07 ± 23.37 | 47.22 ± 22.95 | 0.422 | 0.657 |
| VAS | 3.00 (4.00, 0.75) | 3.00 (4.00, 3.00) | 3.00 (6.00, 2.00) | 1.047 | 0.5921 |
Table 9 Clinical scores after conservative hip preservation treatment for osteonecrosis of the femoral head based on lesion size
| Items | < 15% | 15%-30% | > 30% | H | P value |
| Harris | 82.50 (93.00, 67.00) | 77.00 (93.00, 68.00) | 72.00 (85.00, 60.25) | 3.638 | 0.162 |
| iHOT-12 | 111.00 (120.00, 98.00) | 104.00 (110.00, 93.50) | 98.00 (106.00, 91.25) | 12.344 | 0.0021 |
| WOMAC | 30.00 (53.50, 18.00) | 45.00 (61.50, 28.50) | 46.00 (66.00, 36.00) | 6.456 | 0.0401 |
| VAS | 2.00 (3.00, 0.00) | 3.00 (4.50, 2.50) | 3.00 (5.50, 3.00) | 8.872 | 0.0121 |
Table 10 Clinical scores after conservative hip preservation treatment for osteonecrosis of the femoral head based on collapse degree
- Citation: Chen WH, Zhuang C, Guo WJ, Guo WX, He W, Pan Y. Outcomes of the conservative hip preservation treatment in patients with osteonecrosis of the femoral head: With 4-year follow-up. World J Orthop 2025; 16(12): 110291
- URL: https://www.wjgnet.com/2218-5836/full/v16/i12/110291.htm
- DOI: https://dx.doi.org/10.5312/wjo.v16.i12.110291
